Home Cart Sign in  
Chemical Structure| 878978-76-8 Chemical Structure| 878978-76-8

Structure of ML-098
CAS No.: 878978-76-8

Chemical Structure| 878978-76-8

ML-098

CAS No.: 878978-76-8

ML-098 is an activator of the GTP-binding protein Rab7 with an EC50 of 77.6 nM

Synonyms: CID-7345532

4.5 *For Research Use Only !

Cat. No.: A736431 Purity: 99%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg ł§Ç¶ÊÊ Inquiry Inquiry
5mg łòď¶ÊÊ Inquiry Inquiry
10mg łóî¶ÊÊ Inquiry Inquiry
25mg łÇÊó¶ÊÊ Inquiry Inquiry
50mg łÇ§Ê¶ÊÊ Inquiry Inquiry
100mg łËËʶÊÊ Inquiry Inquiry
250mg ł§ď§¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • 1mg

    ł§Ç¶ÊÊ

  • 5mg

    łòď¶ÊÊ

  • 10mg

    łóî¶ÊÊ

  • 25mg

    łÇÊó¶ÊÊ

  • 50mg

    łÇ§Ê¶ÊÊ

  • 100mg

    łËËʶÊÊ

  • 250mg

    ł§ď§¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML-098

CAS No. :878978-76-8
Formula : C19H19NO3
M.W : 309.36
SMILES Code : O=C(C1=CN(CCOC2=CC(C)=CC=C2C)C3=C1C=CC=C3)O
Synonyms :
CID-7345532
MDL No. :MFCD08672264

Safety of ML-098

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of ML-098

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
NMCMs (Neonatal mouse cardiomyocytes) 0.5 μM To study the effect of ML-098 on LDs-lysosome colocalization, results showed that ML-098 increased LDs-lysosome colocalization and reduced LDs accumulation. PMC11304244
HL-1 cells 0.5 μM 24 h To study the effect of ML-098 on Rab7-Rilp interaction, results showed that ML-098 enhanced Rilp recruitment and promoted LDs degradation. PMC11304244

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Diabetic cardiomyopathy model Intraperitoneal injection 1 mg/kg Five consecutive days a week for two weeks To study the effect of ML-098 on cardiac function in diabetic cardiomyopathy mice, results showed that ML-098 improved diastolic function and reduced LDs accumulation. PMC11304244
Rats Chronic hypoxia/SU5416 model Subcutaneous injection 1.0 mg/kg 5 times a week for 21 days ML-098 treatment reduced severe pulmonary hypertension induced by chronic hypoxia/SU5416, decreasing right ventricular systolic pressure, Fulton index, pulmonary artery wall thickness, pulmonary artery occlusion, and mural cell proliferation, while increasing pulmonary artery acceleration time/pulmonary artery ejection time, tricuspid annular plane systolic excursion, and cardiac output. PMC10836802

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.23mL

0.65mL

0.32mL

16.16mL

3.23mL

1.62mL

32.32mL

6.46mL

3.23mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories